Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.
The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.
The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.
An investigative treatment for hepatitis C got strong results in patients who had failed previous...
Swiss drug maker Roche has bought the rights to an investigative treatment for hepatitis C,...
Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...